Please login to the form below

Not currently logged in

Incyte and Novartis join coronavirus efforts with phase 3 study

Novartis day

Ruxolitinib helps to inhibit immune cells from attacking the body’s own immune system

Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring

Phase 1 trial was initiated in record time, after vaccine candidate fast-tracked by US government

Merck’s Keytruda beats chemo in first-line colorectal cancer

merck-keytruda-pembrolizumab-melanomaAchieved “clinically meaningful” improvement in progression-free survival

OSE lung cancer vaccine clears phase 3 hurdle, but COVID-19 stalls programme

Vaccine vialTedopi is aimed at stimulating T-lymphocytes against tumours

Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK

GileadThe pair of phase 3 trials will take place across 15 clinical sites in the UK

UK government reveals only 2,000 key NHS staff have been tested for coronavirus

nhsHealth officials face criticism over strict production measures

MHRA raises concerns over fraudulent coronavirus tests

Coronavirus mapAs Amazon and Boots partner on at-home testing kits

BMS and bluebird bio file ide-cel CAR-T for multiple myeloma in US

BMS buildingIde-cel has breakthrough designation from the FDA

Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs

Eli Lilly new HQThe five-year deal includes Sitryx’ two lead projects

Digital medcommsCurrent and future trends for developing digital medical communications

Evolving digital trends and user needs

Latest appointments

COVID-19 Updates and Daily News

Featured jobs


Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...